Why the study?
Are ADP-induced aggregation and inhibition of stimulated adenylate cyclase mediated by different receptors in human platelets?
Are ADP-induced aggregation and inhibition of stimulated adenylate cyclase mediated by different receptors in human platelets?
The strong correlation between the inhibition of ADP-induced aggregation and adenylate cyclase inhibition suggests both effects are mediated by the same ADP receptor on human platelets.
Answers are grounded in this paper and cite their sources.
Supports shared ADP receptor mediation in platelets; leaves open human in vivo confirmation.
1 Adenosine 5'-diphosphate (ADP) induces human platelet aggregation and noncompetitively inhibits stimulated human platelet adenylate cyclase; it has been suggested that these two effects are mediated by separate ADP receptors on the platelet surface. 2 Adenosine 5'-triphosphate and seven adenine nucleotide analogues were tested as inhibitors of both effects of ADP on human platelets, and were found to be competitive. 3 pA2 values were calculated for each antagonist for inhibition of both effects of ADP, and a good correlation (correlation coefficient 0.87; p less than 0.01) was found between the pA2 values for inhibition of ADP-induced aggregation and the pA2 values for inhibition of the effect of ADP on stimulated adenylate cyclase. 4 Such a correlation does not support the suggestion that ADP-induced aggregation and the inhibition by ADP of stimulated adenylate cyclase are mediated by two separate receptors.
No takes yet. Share an insight, caveat, or question.
Cusack et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: